A treatment best known for smoothing wrinkles is quietly changing lives for people living with overactive bladder, a condition that causes urgency, frequency, and incontinence. Did you know with a ...

FDA approved Imfinzi with gemcitabine and cisplatin for muscle-invasive bladder cancer, based on NIAGARA trial results showing improved survival outcomes. The regimen integrates immunotherapy in pre- ...

Bladder cancer staging is numbered from stage 0 to stage IV. Your doctor will use staging to decide what kind of treatment is needed for your bladder cancer. Your doctor will also give your cancer ...

The symptoms of bladder cancer are often mistaken for other diseases and may include hematuria (blood in the urine) and urinary frequency. If diagnosed early, success rates for treatment—which may ...

These discussions focused on current challenges and advancements in the management of non–muscle invasive bladder cancer (NMIBC), touching on approved therapies such as nadaofaragene firadenovec ...

A groundbreaking targeted treatment for the most common type of bladder cancer has been approved for use by the NHS, offering new hope to hundreds of patients. The National Institute of Health and ...

As you process your diagnosis, moving forward with treatment is crucial to optimizing your health and recovery. A person's precise bladder cancer treatment plan will depend on a number of factors, ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Your bladder is part of the body system that filters waste products out of your blood and makes urine (wee). This is called the urinary system (or urinary tract). It includes the: You have two kidneys ...

In this patient population, bladder removal remains a standard treatment, but many patients are elderly, have significant comorbidities, or are unwilling to undergo radical surgery, making ...

New data from the SunRISe-1 study of TAR-200 in patients with high-risk, non-muscle-invasive bladder cancer (HR-NMIBC) that has not responded to standard BCG treatment build the case for the drug ...